CO62 Prophylaxis Treatment for Patients With Hemophilia A Without Inhibitors: Experience Monitoring Survey on the Use of Damoctocog Alfa Pegol
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.141
https://www.valueinhealthjournal.com/article/S1098-3015(22)02345-2/fulltext
Title :
CO62 Prophylaxis Treatment for Patients With Hemophilia A Without Inhibitors: Experience Monitoring Survey on the Use of Damoctocog Alfa Pegol
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02345-2&doi=10.1016/j.jval.2022.09.141
First page :
Section Title :
Open access? :
No
Section Order :
10973